All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study

• Asıl Yazarlar: Oliver J. Kennedy (Yazar), Jonathan A. Fallowfield (Yazar), Robin Poole (Yazar), Peter C. Hayes (Yazar), Julie Parkes (Yazar), Paul J. Roderick (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2021-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Chronic liver disease (CLD) is a growing cause of morbidity and mortality worldwide, particularly in low to middle-income countries with high disease burden and limited treatment availability. Coffee consumption has been linked with lower rates of CLD, but little is known about t...